Impact of surgical weight loss on novel P-wave-related variables which are nominated as predictors of atrial arrhythmias.
atrial arrhythmia
electrocardiogram
obesity
p wave
surgery
Journal
Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
revised:
30
06
2021
received:
20
05
2021
accepted:
25
07
2021
pubmed:
28
7
2021
medline:
1
2
2022
entrez:
27
7
2021
Statut:
ppublish
Résumé
Bariatric surgery has been associated with reduced cardiovascular mortality and morbidity in obese patients. In this study, we aimed to evaluate the alterations of novel P-wave related atrial arrhythmia predictors in patients who achieved effective weight loss with bariatric surgery. The study included 58 patients who underwent bariatric surgery. We measured heart rate, PR, P wave (PW) max, PW min, Average P axis, P wave peak time (PWPT) in lead D2 and lead V1, terminal force in lead V1 (V1TF), and we estimated P wave dispersion (PWdis) interval both pre-operation and 6 months after operation. Heart rate, PR, PW max, PW min, PWdis, Average P axis, PWPTD2, PWPTV1 and V1TF values, which were close to the upper limit in the pre-op period, showed statistically significant decreases at 6 months after the operation. The most prominent changes were observed in PW dis (51.15 ± 9.70 ms vs. 48.79 ± 9.50 ms, p = .010), PWPTD2 (55.75 ± 6.91 ms vs. 50.59 ± 7.67 ms, p < .001), PWPTV1 (54.10 ± 7.06 ms vs. 48.05 ± 7.64 ms, p < .001) and V1TF (25 [43.1%] vs. 12 [20.7%], p < .001). The results of our study indicated that bariatric surgery has positive effects on the regression of ECG parameters which are predictors of atrial arrhythmias, particularly atrial fibrillation (AF).
Sections du résumé
BACKGROUND
BACKGROUND
Bariatric surgery has been associated with reduced cardiovascular mortality and morbidity in obese patients. In this study, we aimed to evaluate the alterations of novel P-wave related atrial arrhythmia predictors in patients who achieved effective weight loss with bariatric surgery.
METHODS
METHODS
The study included 58 patients who underwent bariatric surgery. We measured heart rate, PR, P wave (PW) max, PW min, Average P axis, P wave peak time (PWPT) in lead D2 and lead V1, terminal force in lead V1 (V1TF), and we estimated P wave dispersion (PWdis) interval both pre-operation and 6 months after operation.
RESULTS
RESULTS
Heart rate, PR, PW max, PW min, PWdis, Average P axis, PWPTD2, PWPTV1 and V1TF values, which were close to the upper limit in the pre-op period, showed statistically significant decreases at 6 months after the operation. The most prominent changes were observed in PW dis (51.15 ± 9.70 ms vs. 48.79 ± 9.50 ms, p = .010), PWPTD2 (55.75 ± 6.91 ms vs. 50.59 ± 7.67 ms, p < .001), PWPTV1 (54.10 ± 7.06 ms vs. 48.05 ± 7.64 ms, p < .001) and V1TF (25 [43.1%] vs. 12 [20.7%], p < .001).
CONCLUSIONS
CONCLUSIONS
The results of our study indicated that bariatric surgery has positive effects on the regression of ECG parameters which are predictors of atrial arrhythmias, particularly atrial fibrillation (AF).
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1516-1522Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Yılmaz M, Altin C, Tekin A. et al. Assessment of atrial fibrillation and ventricular arrhythmia risk after bariatric surgery by P Wave/QT interval dispersion. Obes Surg. 2018;28:932-938.
Chen H, Wang X, Xiong C, Zou H. The negative effects of obesity on heart, especially the electrophysiology of the heart. Artif Cells Nanomed. Biotechnol. 2020;48:1055-1062.
Aggarwal R, Harling L, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H. The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcomes. Obes Surg. 2016;26:1030-1040.
Ashrafian H, Darzi A, Athanasiou T. Bariatric surgery: can we afford to do it or deny doing it?. Frontline Gastroenterol. 2011;2:82-89.
Nguyen NT, Nguyen B, Gebhart A, Hohmann S. Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg. 2013;216:252-257.
Applegate TE. Atrial arrhythmias. 2000:677-708.
Vizzardi E, Curnis A, Latini MG, et al. Rick factors for atrial fibrillation recurrence: a literature review. J Cardiovasc Med (Hagerstown). 2014;15:235-253.
Dilaveris PE, Kennedy HL. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clin Cardiol. 2017;40:413-418.
Mangiafico V, Saberwal B, Lavalle C, et al. Impact of obesity on atrial fibrillation ablation. Arch Cardiovasc Dis. 2020;113:551-563.
Gutierrez C, Blanchard DG. Diagnosis and treatment of atrial fibrillation. Am Fam Physician. 2016;94:442-452.
Bagliani G, Leonelli F, Padeletti L. P wave and the substrates of arrhythmias originating in the atria. Card Electrophysiol Clin. 2017;9:365-382.
Haslam DW, James WPT. Obesity. Lancet. 2005;366:1197-1209.
Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atherosclerosis Rep. 2002;4:448-453.
Bayés de LunaA. [Supraventricular arrhythmia: electrocardiographic aspects]. Medwave. 2016;16:e6815.
Go AS, Reynolds K, Yang J, et al. Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study. JAMA Cardiol. 2018;3:601-608.
Assessing atrial fibrillation substrates by P wave analysis: a comprehensive review. High Blood Press Cardiovasc Prev. 2020;27:341-347.
Acampa M, Lazzerini PE, Guideri F, Tassi R, Cartocci A, Martini G. P wave dispersion and silent atrial fibrillation in cryptogenic stroke: the pathogenic role of inflammation. Cardiovasc Hematol Disord Drug Targets. 2019;19:249-252.
Yıldırım E, Günay N, Bayam E, Keskin M, Ozturkeri B, Selcuk M. Relationship between paroxysmal atrial fibrillation and a novel electrocardiographic parameter P wave peak time. J Electrocardiol. 2019;57:81-86.
Öz A, Cinar T, C KızıltoGüler, et al. Novel electrocardiography parameter for paroxysmal atrial fibrillation in acute ischaemic stroke patients: p wave peak time. Postgrad Med J. 2020;96:584-588.
Liu T, Fu Z, Korantzopoulos P, Zhang X, Wang S, Li G. Effect of obesity on p-wave parameters in a Chinese population. Ann Noninvasive Electrocardiol. 2010;15:259-263.
Yılmaz M, Altın C, Tekin A, et al, Assessment of atrial fibrillation and ventricular arrhythmia risk after bariatric surgery by p wave/qt interval dispersion. Obes Surg. 2018;28(4):932-938.
Baturova MA, Sheldon SH, Carlson J, Brady PA, Lin G, Rabinstein AA. Electrocardiographic and echocardiographic predictors of paroxysmal atrial fibrillation detected after ischemic stroke. BMC Cardiovasc Disord. 2016;16:209.
Jurkko R, Vaananen H, Mantynen V, Kuusisto J, Mäkijärvi M, Toivonen L. High-resolution signal-averaged analysis of atrial electromagnetic characteristics in patients with paroxysmal lone atrial fibrillation. Ann Noninvasive Electrocardiol. 2008;13:378-385.
Nemirovsky D, Hutter R, Gomes JA. The electrical substrate of vagal atrial fibrillation as assessed by the signal-averaged electrocardiogram of the P wave. Pacing Clin Electrophysiol. 2008;31:308-313.
Pathak RK, Mahajan R, Lau DH, Sanders P, The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol. 2015;31:203-210.
Fenger-Grøn M, Vinter N, Frost L. Body mass and atrial fibrillation risk: status of the epidemiology concerning the influence of fat versus lean body mass. Trends Cardiovasc Med. 2020;30:205-211.
Hatem SN, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res. 2014;102:205-213.
Zhou M, Wang H, Chen J, Zhao L. Epicardial adipose tissue and atrial fibrillation: possible mechanisms, potential therapies, and future directions. Pacing Clin Electrophysiol. 2020;43:133-145.
Wang A, Green JB, Halperin JL. Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol. 2019;74:1107-1115.
Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Diabetes Complications. 2018;32:501-511.
Goudis CA, Ketikoglou DG. Obstructive sleep and atrial fibrillation: pathophysiological mechanisms and therapeutic implications. Int J Cardiol. 2017;230:293-300.
Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020;323:1389-1400.
Linz D, McEvoy RD, Cowie MR, et al. Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a review. JAMA Cardiol. 2018;3:532-540.
Kallistratos MS, Poulimenos LE, Manolis AJ. Atrial fibrillation and arterial hypertension. Pharmacol Res. 2018;128:322-326.
Morseth B, Løchen ML, Ariansen I, Myrstad M, Thelle DS. The ambiguity of physical activity, exercise and atrial fibrillation. Eur J Prev Cardiol. 2018;25:624-636.
Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol. 2017;70:2022-2035.